Here's my concern, how many times have we seen these small biotechs have a stock offering right before bad clinical trial results? It happens all the time. If you have good news coming why would you have an offering beforehand? It's better to wait until after the good news when your stock price rises. Instead it makes all the sense in the world to have an offering before bad news that will cause your stock price to plummet. A recent example is CRBP. They had a stock offering a month before the disasterous lenabasum clinical trial that dumped their stock 80%.
Market Data 
Markets 
